12-O-tetradecanoyl phorbol 13-acetate, protein kinase C (PKC) activator, protects human leukemia HL-60 cells from taxol-induced apoptosis: Possible role for extracellular signal-regulated kinase

Immunopharmacology and Immunotoxicology

Volumn 22, Issue 1, 2000, Pages 61-73

  Pae, Hyun Ock ^a   Yoo, Ji Chang ^a   Choi, Byung Min ^a   Lee, Eon Jeong ^a   Song, Yung Sun ^a   Chung, Hun Taeg ^a  

^a Wonkwang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; DNA FRAGMENT; MITOGEN ACTIVATED PROTEIN KINASE; PACLITAXEL; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR; STAUROSPORINE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG RESEARCH; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0034103022     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.3109/08923970009016406     Document Type: Article

References (20)

1. Papadimitriou, C. A., Sarris, K., Moulopoulos, L. A., Fountzilas, G., Anagnostopoulos, A., Voulgaris, Z., Gika, D., Giannakoulis, N., Diakomanolis, E. and imopoulos, M. A., Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix, J. Clin. Oncol., 17:761-766, 1999.
2. Sekine, I., Nishiwaki, Y., Watanabe, K., Yoneda, S., and Saijo, N., Phase II study of 3-hour infusion of paclitaxel in previously untreated non-small cell lung cancer, Clin. Cancer Res. 2:941-945, 1996.
3. Ojima, I., Chakravarty, S., Inoue, T., Lin, S., He, L., Horwitz, S. B., Kuduk, S. D., and Danishefsky, S. J., A common pharmacophore for cytotoxic natural products that stabilize microtubules, Proc. Natl. Acad. Sci. U. S. A., 96:4256-4261, 1999.
4. Lieu, C. H., Chang, Y. N., and Lai, Y. K., Dual cytotoxic mechanisms of submicromolar taxol on human leukemia HL-60 cells, Biochem. Pharmacol., 53:1587-1596, 1997.
5. Rathmell, J. C. and Thompson, C. B., The central effectors of cell death in the immune system, Annu. Rev. Immunol, 17:781-828, 1999.
6. Glazer, R. I., The protein kinase ABC's of signal transduction as targets for drug development, Curr. Pharm. Des., 4:277-290, 1998.
7. Kyriakis, J. M., Making the connection: coupling of stress-activated ERK / MAPK (extracellular-signal-regulated kinase / mitogen-activated protein kinase) core signalling modules to extracellular stimuli and biological responses, Biochem. Soc. Symp., 64:29-48, 1999.
8. Terada, Y., Nakashima, O., Inoshita, S., Kuwahara, M., Sasaki, S., and Marumo, F., Mitogen-activated protein kinase cascade and transcription factors: the opposite role of MKK3 / 6-p38K and MKK1-MAPK, Nephrol. Dial. Transplant, 14:45-47, 1999.
9. Neary, J. T., Kang, Y., Bu, Y., Yu, E., Akong, K., and Peters, C. M., Mitogenic signaling by ATP / P2Y purinergic receptors in astrocytes: involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidylinositol-specific phospholipase C / calcium pathway, J. Neurosci., 19:4211-4220, 1999.
10. Miranti, C. K., Ohno, S., and Brugge, J. S., Protein kinase C regulates integrin-induced activation of the extracellular regulated kinase pathway upstream of She, J. Biol. Chem., 274:10571-1081, 1999.
11. Bhalla, K., Ibrado, A. M., Tourkina, E., Tang, C., Mahoney, M. E., Huang, Y., Taxol induces internucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells, Leukemia, 7:563-568, 1993.
12. 2+ release pathway, Food Chem. Toxicol., 36:513-520, 1998.
13. Tokuda, H., Kozawa, O., Harada, A., and Uematsu, T., p42 / p44 mitogen-activated protein kinase activation is involved in prostaglandin F2alpha-induced interleukin-6 synthesis in osteoblasts, Cell Signal., 11:325-330, 1999.
14. Wang, S., Guo, C. Y., Castillo, A., Dent, P., and Grant, S., Effect of bryostatin 1 on taxol-induced apoptosis and cytotoxicity in human leukemia cells (U937), Biochem. Pharmacol., 56:635-644, 1998.
15. Stadheim, T. A. and Kucera, G. L., Extracellular signal-regulated kinase (ERK) activity is required for TPA-mediated inhibition of drug-induced apoptosis, Biochem. Biophys. Res. Commun., 245:266-271, 1998.
16. Merritt, J. E., Sullivan, J. A., Drew, L., Khan, A., Wilson, K., Mulqueen, M., Harris, W., Bradshaw, D., Hill, C. H., Rumsby, M., and Warr, R., The bisindolylmaleimide protein kinase C inhibitor, Ro32-2241, reverses multidrug resistance in KB tumour cells, Cancer Chemother. Pharmacol. 43:371-378, 1999.
17. Masanek, U., Stammler, G., and Volm, M., Messenger RNA expression of resistance proteins and related factors in human ovarian carcinoma cell lines resistant to doxorubicin, taxol and cisplatin, Anticancer Drugs, 8(2): 189-198, 1997.
18. Volm, M., Zintl, F., Edler, L., and Sauerbrey, A., Prognostic value of protein kinase C, proto-oncogene products and resistance-related proteins in newly diagnosed childhood acute lymphoblastic leukemia, Med. Pediatr. Oncol., 28:117-26, 1997.
19. Jun, C. D., Pae, H. O., Kwak, H. J., Yoo, J. C., Choi, B. M., Oh, C. D., Chun, J. S., Paik, S. G., Park, Y. H., Chung, H. T., Modulation of nitric oxide-induced apoptotic death of HL-60 cells by protein kinase C and protein kinase A through mitogen-activated protein kinases and CPP32-like protease pathways, Cell Immunol., 194:36-46, 1999.
20. Cuvillier, O., Pirianov, G., Kleuser, B., Vanek, P. G., Coso, O. A., Gutkind, S., Spiegel, S., Suppression of ceramide-mediated programmed cell death by sphingosine-1 -phosphate, Nature, 381(6585) :800-3:800-803, 1996.